Key references: Monitoring testosterone replacement therapy

Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, et al. Adverse events associated with testosterone administration. N Engl J Med 2010;363(2):109–22. https://www.ncbi.nlm.nih.gov/pubmed/20592293
Behre HM, Bohmeyer J, Nieschlag E. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf) 1994;40(3):341–9. https://www.ncbi.nlm.nih.gov/pubmed/7514512
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018;103(5):1715–44. https://www.ncbi.nlm.nih.gov/pubmed/29562364
Budoff MJ, Ellenberg SS, Lewis CE, Mohler ER, Wenger NK, Bhasin S, et al. Testosterone treatment and coronary artery plaque volume in older men with low testosterone. JAMA 2017;317(7):708–16. https://www.ncbi.nlm.nih.gov/pubmed/28241355
Cancer Council Australia, Prostate Cancer Foundation of Australia. https://www.cancer.org.au/clinical-guidelines/prostate-cancer/psa-testing. Sydney: Cancer Council Australia; 2016. https://www.cancer.org.au/clinical-guidelines/prostate-cancer/psa-testing
Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, et al. Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95(6):2560–75. https://www.ncbi.nlm.nih.gov/pubmed/20525906
Giannoulis MG, Martin FC, Nair KS, Umpleby AM, Sonksen P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev 2012;33(3):314–77. https://www.ncbi.nlm.nih.gov/pubmed/22433122
Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf) 2005;63(4):381–94. https://www.ncbi.nlm.nih.gov/pubmed/16181230
Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005;63(3):280–93. https://www.ncbi.nlm.nih.gov/pubmed/16117815
Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 2006;27(2):135–7. https://www.ncbi.nlm.nih.gov/pubmed/16474020
Royal Australian College of General Practitioners (RACGP) . Familial prostate cancer. In: Genomics in general practice. East Melbourne, Vic: RACGP; 2018. https://www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Genomics-in-general-practice.pdf
Royal Australian College of General Practitioners (RACGP) . Prostate cancer screening [Patient information sheet]. East Melbourne, Vic: RACGP; 2015. https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/prostate-cancer-screening
Yeap BB, Grossmann M, McLachlan RI, Handelsman DJ, Wittert GA, Conway AJ, et al. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. Med J Aust 2016;205(5):228–31. https://www.ncbi.nlm.nih.gov/pubmed/27581270